Comment on “The End of Phase 3 Clinical Trials in Biosimilars Development?”
Niazi, Sarfaraz K.Language:
english
Journal:
BioDrugs
DOI:
10.1007/s40259-018-0330-1
Date:
January, 2019
File:
PDF, 730 KB
english, 2019